About Alnylam Pharma (ALNY)
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on the use of its N-acetylgala... Read more
- USD255.48
- USD270.20
- USD252.79
- USD304.39
- 13.60%
- 2.3B
- 48.00
- 965.98k
- 32.7B
- 144.73
- 79.60%
Stock News
37 minutes ago
Crypto broker eToro’s IPO to test the waters for stock-market newcomers
MarketWatch
40 minutes ago
Consumer prices show mild increase, but trade wars likely to add to inflation despite reduced tariffs
MarketWatch
47 minutes ago
AMC is taking this bold move to capitalize on a booming box office
MarketWatch
1 hour ago
U.S.-China trade war pushed global supply chain near breaking point, new data shows
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
